Register for the ATN Innovation Summit on June 16-17 in NYC
The Event Fitness & Wellness Owners and Operators Can't Miss.
Courtney Rehfeldt is a senior staff writer at Athletech News, where she reports on the evolving intersection of fitness, wellness and business. She regularly interviews industry leaders, founders and innovators and attends industry events to report on emerging trends firsthand. She began her career in broadcast media at Paramount before joining ATN and previously contributed to several outlets, including two weekly New York-based papers. Her short creative writing has appeared in the New York Times’ Metropolitan Diary section. She holds a bachelor’s degree in media and communications from SUNY Old Westbury.
Planet Fitness and other low-price gym brands are seeing strong increases in foot traffic as many Americans trade down.
Last Rep, a Tampa Bay THC seltzer startup, is targeting athletes who just crushed a workout, citing rising demand for functional drinks.
Three entrepreneurs are leading SweatHouz's expansion into New York City with 12 planned contrast-therapy studios, beginning with Tribeca.
HFA's latest policy briefing covered federal rule-making, state-level wins, Medicare expansion and what the midterm elections mean for the fitness industry.
A luxury Pilates brand is turning a vintage New York City carriage house into the largest Pilates studio in the U.S.
Health metrics such as sleep scores and VO2 max are now status symbols. A neuroscientist says the obsession runs deeper than wellness — and so do the risks.
Valentine’s Day fitness deals are heating up in 2026, from free gym days to IV therapy and partner workouts across top wellness brands.
Cambiotics has landed $4.7M to bring a PFAS-targeting probiotic to market as concern over “forever chemicals” grows.
Skelcore has tapped Cybex Eagle creator Roy Simonson and Freemotion veteran Hillis Lake to drive strength training equipment innovation.
Prime IV Hydration & Wellness added 53 locations in 2025 and enters this year with expansion on the roadmap as IV-therapy demand grows.
Sign Up to Our Newsletter
